drugset / Trial / NCT07048886
Rocklatan Adds Pressure Reduction After MIGS (Minimally Invasive Glaucoma Surgery)
RandomizedParallel-groupDouble-blindTreatment
Summary
The primary objective of this study is to determine if the addition of Rocklatan post-Hydrus will provide additional intraocular pressure lowering.
Timeline
- Start
- 2025-07-15
- Primary completion
- 2026-12-31
- Completion
- 2026-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Rocklatan | Other / unclassified | 0.005 % | — |
| Comparator | Rocklatan | Other / unclassified | 0.02 % | — |